… anti-chemokine strategies to better treat atherosclerosis we need to consider the various
immune cells that contribute to development and progression of atherosclerosis, their cellular …

… Atherosclerosis and Inflammation Coronary heart disease is nowadays regarded as a low-grade
chronic inflammatory process.[48,49] Atherogenesis is initiated by endothelial injury …

… inflammatory effects of serpin administration, colchicine and intravenous HDL-directed treatment
… for these novel anti-inflammatory treatments at both the experimental and clinical levels. …

… processes and molecular mechanisms. Here we highlight the current view on atherosclerosis
and … Our understanding of the atherogenic process has been considerably refined by the …

… Concomitant up-regulation of pro-inflammatory signalling pathways in vascular and blood
… key pro-inflammatory modulators as therapeutic targets for treatment of atherosclerosis. The …

… These foam cells play a decisive role in atherosclerosis … -γ), a primary inflammatory cytokine
in progressive atherosclerosis, … Here, we discuss the pro-atherosclerotic implication of this …

… Since anti-inflammatory drugs currently receive more and more attention with respect to …
treatment of atherosclerosis, we will summarize possible secondary effects of anti-inflammatory …

… The first steps towards the development of anti-inflammatory treatments in atherosclerosis
were accomplished while studying patients with chronic inflammatory and autoimmune …

… that link inflammation and atherosclerosis and how we are at the threshold of translating
inflammation biology to improved patient care and more precise targeting of therapies. …

… , which may aggravate atherosclerotic lesions, have lessened the enthusiasm for corticosteroid
therapy as a therapeutic option to mitigate inflammatory processes in atherosclerosis. …